187 related articles for article (PubMed ID: 8993240)
1. Heparin coating with aprotinin reduces blood activation during coronary artery operations.
Baufreton C; Jansen PG; Le Besnerais P; te Velthuis H; Thijs CM; Wildevuur CR; Loisance DY
Ann Thorac Surg; 1997 Jan; 63(1):50-6. PubMed ID: 8993240
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome after coronary surgery with heparin-coated extracorporeal circuits for cardiopulmonary bypass.
Baufreton C; Le Besnerais P; Jansen P; Mazzucotelli JP; Wildevuur CR; Loisance DY
Perfusion; 1996 Nov; 11(6):437-43. PubMed ID: 8971943
[TBL] [Abstract][Full Text] [Related]
3. Reduction of blood activation in patients receiving aprotinin during cardiopulmonary bypass for coronary artery surgery.
Baufreton C; Velthuis HT; Jansen PG; Besnerais PL; Wildevuur CH; Loisance DY
ASAIO J; 1996; 42(5):M417-23. PubMed ID: 8944919
[TBL] [Abstract][Full Text] [Related]
4. Specific complement inhibition with heparin-coated extracorporeal circuits.
te Velthuis H; Jansen PG; Hack CE; Eijsman L; Wildevuur CR
Ann Thorac Surg; 1996 Apr; 61(4):1153-7. PubMed ID: 8607674
[TBL] [Abstract][Full Text] [Related]
5. Elastase release following myocardial ischemia during extracorporeal circulation (ECC) -- marker of ongoing systemic inflammation?
Boeken U; Feindt P; Schulte HD; Gams E
Thorac Cardiovasc Surg; 2002 Jun; 50(3):136-40. PubMed ID: 12077684
[TBL] [Abstract][Full Text] [Related]
6. Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study.
Fosse E; Thelin S; Svennevig JL; Jansen P; Mollnes TE; Hack E; Venge P; Moen O; Brockmeier V; Dregelid E; Haldén E; Hagman L; Videm V; Pedersen T; Mohr B
Eur J Cardiothorac Surg; 1997 Feb; 11(2):320-7. PubMed ID: 9080162
[TBL] [Abstract][Full Text] [Related]
7. Heparin-coated circuits and aprotinin prime for coronary artery bypass grafting.
Jansen PG; Baufreton C; Le Besnerais P; Loisance DY; Wildevuur CR
Ann Thorac Surg; 1996 May; 61(5):1363-6. PubMed ID: 8633942
[TBL] [Abstract][Full Text] [Related]
8. [Effect of aprotinin on blood loss reduction after extracorporeal circulation].
Ueyama K; Kawasuji M; Sakakibara N; Tedoriya T; Takahashi M; Watanabe Y
Nihon Kyobu Geka Gakkai Zasshi; 1993 Oct; 41(10):2093-9. PubMed ID: 7693833
[TBL] [Abstract][Full Text] [Related]
9. Heparin-coated extracorporeal circulation in combination with low dose systemic heparinization reduces early postoperative blood loss in cardiac surgery.
Mirow N; Zittermann A; Koertke H; Maleszka A; Knobl H; Coskun T; Kleesiek K; Koerfer R
J Cardiovasc Surg (Torino); 2008 Apr; 49(2):277-84. PubMed ID: 18431350
[TBL] [Abstract][Full Text] [Related]
10. Heparin-level-based anticoagulation management during cardiopulmonary bypass: a pilot investigation on the effects of a half-dose aprotinin protocol on postoperative blood loss and hemostatic activation and inflammatory response.
Koster A; Huebler S; Merkle F; Hentschel T; Gründel M; Krabatsch T; Tambeur L; Praus M; Habazettl H; Kuebler WM; Kuppe H
Anesth Analg; 2004 Feb; 98(2):285-290. PubMed ID: 14742356
[TBL] [Abstract][Full Text] [Related]
11. 'High dose' aprotinin and heparin-coated circuits: clinical efficacy and inflammatory response.
Parolari A; Alamanni F; Gherli T; Salis S; Spirito R; Foieni F; Rossi F; Bertera A; Oddono P; Biglioli P
Cardiovasc Surg; 1999 Jan; 7(1):117-27. PubMed ID: 10073771
[TBL] [Abstract][Full Text] [Related]
12. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
[TBL] [Abstract][Full Text] [Related]
13. Low dose systemic heparinization combined with heparin-coated extracorporeal circulation. Effects related to platelets.
Mirow N; Brinkmann T; Minami K; Tenderich G; Schulte-Eistrup S; Kleesiek K; Körfer R
J Cardiovasc Surg (Torino); 2001 Oct; 42(5):579-85. PubMed ID: 11562580
[TBL] [Abstract][Full Text] [Related]
14. Activation of fibrinolysis in the pericardial cavity after cardiopulmonary bypass.
Khalil PN; Ismail M; Kalmar P; von Knobelsdorff G; Marx G
Thromb Haemost; 2004 Sep; 92(3):568-74. PubMed ID: 15351853
[TBL] [Abstract][Full Text] [Related]
15. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
16. Heparin coating of an extracorporeal circuit partly improves hemostasis after cardiopulmonary bypass.
Boonstra PW; Gu YJ; Akkerman C; Haan J; Huyzen R; van Oeveren W
J Thorac Cardiovasc Surg; 1994 Jan; 107(1):289-92. PubMed ID: 8283898
[TBL] [Abstract][Full Text] [Related]
17. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
[TBL] [Abstract][Full Text] [Related]
18. Fibrinolysis-adjusted perioperative low-dose aprotinin reduces blood loss in bypass operations.
Misfeld M; Dubbert S; Eleftheriadis S; Siemens HJ; Wagner T; Sievers HH
Ann Thorac Surg; 1998 Sep; 66(3):792-9. PubMed ID: 9768932
[TBL] [Abstract][Full Text] [Related]
19. Low-dose and high-dose aprotinin improve hemostasis in coronary operations.
Speekenbrink RG; Wildevuur CR; Sturk A; Eijsman L
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):523-30. PubMed ID: 8751522
[TBL] [Abstract][Full Text] [Related]
20. Clotting and fibrinolytic disturbance during lung transplantation: effect of low-dose aprotinin. Groningen Lung Transplant Group.
Gu YJ; de Haan J; Brenken UP; de Boer WJ; Prop J; Van Oeveren W
J Thorac Cardiovasc Surg; 1996 Sep; 112(3):599-606. PubMed ID: 8800145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
